Therapeutics

Precision Medicine Innovative Treatments Psychedelic Therapy Psychedelic Medicine Antimicrobial Strategies Antiviral Treatments Chronic Disease Management Preclinical Research Metabolic Disorders Treatment Development Skin Diseases Non-Pharmaceutical Treatments Cell Therapy Drug Development Infant Health Drug Targets Genetic Medicines Treatment Options Antibody Therapy

UMC Utrecht Reports First FcγRI-Blocking Antibodies With Preclinical Efficacy

The Fc-silent Fabs outcompete IgG at CD64 to block immune-complex engagement without triggering receptor activation.

Duke-NUS Team Publishes Single-Cell Fetal Brain Atlas to Benchmark Parkinson’s Models

UC Davis Mouse Study Finds Psilocybin Worsened Postpartum Behaviors and Produced Lasting Offspring Effects

Mix-and-Go Cubosome Method Achieves Over 98% mRNA Encapsulation and Advances Toward Clinical Scale-Up

Llama-Derived Nanobody Therapy Poised for Human Trials in Schizophrenia